Bionime

Bionime EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bionime (4737.TW) as of Oct 20, 2026 is -197.36 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -128.38 M TWD — a change of 53.73% (lower).

EBITDA

-197.36 MTWD

YoY

53.73%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bionime is 2025 -197.36 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bionime was 2024 -128.38 M TWD. It decreases by 53.73% lower compared to the previous year.

The Bionime EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
239.30 M TWD
Jan 1, 2019
176.53 M TWD
Jan 1, 2020
75.95 M TWD
Jan 1, 2021
93.64 M TWD
Jan 1, 2022
117.13 M TWD
Jan 1, 2023
16.36 M TWD
Jan 1, 2024
-128.38 M TWD
Jan 1, 2025
-197.36 M TWD
The Bionime EBITDA history
YEAREBITDAYoY
-197.36 MTWD+53.73%
-128.38 MTWD-884.74%
16.36 MTWD-86.03%
117.13 MTWD+25.09%
93.64 MTWD+23.29%
75.95 MTWD-56.98%
176.53 MTWD-26.23%
239.30 MTWD-8.65%
261.96 MTWD-4.26%
273.63 MTWD+35.94%
201.29 MTWD+34.82%
149.31 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bionime Stock analysis

What does Bionime do? Bionime Corp is a company that was founded in 2003 and specializes in the development and manufacture of medical devices for measuring blood sugar levels and other cardiovascular tests. Bionime is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bionime stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bionime is -197.36 M TWD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bionime changed from -128.38 M TWD to -197.36 M TWD, representing a 53.73% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Bionime since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Bionime historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Bionime

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Bionime